Serotype Diversity of Foot And Mouth Disease Virus and Molecular Characterization of Serotype O Strains from 2019 and 2020 Outbreaks in Kenya

Document Type : Original Article

Authors

1 Foot-And-Mouth Disease Laboratory Embakasi-Kenya

2 Department of Biochemistry, Microbiology & Biotechnology, Kenyatta University, Nairobi Kenya

3 Department of Biomedical Sciences, College of Veterinary Medicine, Addis Ababa University, Bishoftu, Ethiopia

4 Katholieke Universiteit Leuven, Faculty of Bioscience Engineering, Department of Biosystems, Division Of Animal And Human Health Engineering, Leuven Belgium

5 Laboratory of Molecular Biology, Institute of Primate Research, Karen, Nairobi Kenya

Abstract

Foot and mouth disease (FMD) is a viral infection affecting ruminants and leads to great economic losses. Control and prevention have been a challenge despite the availability of vaccines. The causative agent exists in seven serotypes and is endemic in Kenya, with serotypes O, A, SAT (South African Territory) 1, and SAT 2 and having circulated in the recent past. This study was aimed at determining the current serotype diversity and serotype O variants during the study period. A cross-sectional study was conducted and a total of 267 epithelial samples were collected from animals during the disease outbreaks of 2019 and 2020. Antigen detection was performed using ELISA (Enyme-Linked Immunosorbed Assay). The negative samples were inoculated on LFBK(Line of Fetal Bovine Kidney) monolayer cells followed by a repeat ELISA for CPE(Cytopathic Effect) positive samples. The partial VP1 gene for serotype O samples was amplified and directly sequenced. The generated sequences were analyzed and compared with the vaccine strain. The prevalence of FMDV was 65.9% (176/267) and serotypes SAT 1, O, SAT 2, and A in the order of decreasing prevalence were circulating. Serotype O viruses analyzed belonged to the EA 2 against the EA 1 vaccine strain in use. For better control of the disease, this study recommends close monitoring of the circulating serotypes and topotypes, and, regular vaccine matching to ensure vaccine effectiveness.

Keywords

Main Subjects